Reduced Likelihood of Hospitalization with the JN.1 or HV.1 SARS-CoV-2 Variants Compared to the EG.5 Variant.

Publication Title

The Journal of infectious diseases

Document Type

Article

Publication Date

7-19-2024

Keywords

washington; spokane; pshmc; swedish; covid-19

Abstract

Within a multi-state viral genomic surveillance program, we evaluated whether proportions of SARS-CoV-2 infections attributed to the JN.1 variant and to XBB-lineage variants (including HV.1 and EG.5) differed between inpatient and outpatient care settings during periods of cocirculation. Both JN.1 and HV.1 were less likely than EG.5 to account for infections among inpatients versus outpatients (aOR=0.60 [95% CI: 0.43-0.84; p=0.003] and aOR=0.35 [95% CI: 0.21-0.58; p<0.001], respectively). JN.1 and HV.1 variants may be associated with a lower risk of severe illness. The severity of COVID-19 may have attenuated as predominant circulating SARS-CoV-2 lineages shifted from EG.5 to HV.1 to JN.1.

Keywords: COVID-19; SARS-CoV-2 variants; genomic surveillance; hospitalization; severity.

Specialty

Hospital Medicine

Specialty

Infectious Diseases

DOI

10.1093/infdis/jiae364

Share

COinS